Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oral hypoglycemic agents.

R E Ferner1

  • 1Wolfson Unit of Clinical Pharmacology, Royal Victoria Infirmary, Newcastle upon Tyne, England.

The Medical Clinics of North America
|November 1, 1988
PubMed
Summary
This summary is machine-generated.

Sulfonylureas are key oral diabetes drugs, but their long-term effects and efficacy need more study. Metformin is a safe option for overweight patients without certain health issues.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond clinical toxicology: protecting our poisoned patients.

Journal of the Royal Society of Medicine·2026
Same author

Adverse drug reactions in dermatology.

Clinical and experimental dermatology·2015
Same author

Systemic toxicity related to metal hip prostheses.

Clinical toxicology (Philadelphia, Pa.)·2014
Same author

Laughter and MIRTH (Methodical Investigation of Risibility, Therapeutic and Harmful): narrative synthesis.

BMJ (Clinical research ed.)·2013
Same author

The medico-legal significance of pharmacokinetic interactions with ethanol.

Medicine, science, and the law·2012
Same author

Toxicological evidence in forensic pharmacology.

The International journal of risk & safety in medicine·2012
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
Same journal

Geriatric Care Transitions: Addressing the Complex Needs of Older Adults.

The Medical clinics of North America·2026
Same journal

Using Implementation Science to Understand the Pediatric to Adult Healthcare Transition.

The Medical clinics of North America·2026
See all related articles

Area of Science:

  • Endocrinology
  • Pharmacology

Background:

  • Sulfonylureas are primary oral hypoglycemic agents.
  • Their chronic mechanisms and comparative efficacy remain unclear.

Purpose of the Study:

  • To evaluate the safety and efficacy of sulfonylureas and metformin in diabetes management.
  • To clarify the relative toxicity and hypoglycemia risk associated with different sulfonylureas.

Main Methods:

  • Review of existing data on sulfonylurea and metformin safety and efficacy.
  • Comparative analysis of adverse events and glycemic control.

Main Results:

  • Chlorpropamide identified as the most toxic sulfonylurea.
  • Glyburide poses a similar risk of dangerous hypoglycemia as chlorpropamide.

Related Experiment Videos

  • Tolbutamide or other sulfonylureas can achieve good blood glucose control when timed appropriately.
  • Metformin is as safe as glyburide and beneficial for overweight diabetics without contraindications.

    • Conclusions:

    • Optimized dosing of sulfonylureas can lead to effective blood glucose management.
    • Metformin presents a safe and effective alternative for specific patient populations.
    • Further research is needed to fully elucidate sulfonylurea mechanisms and comparative effectiveness.